About Jeremy Low
Jeremy is a Partner in Allens’ Mergers & Acquisitions team, specialising in complex M&A, strategic investments, consortium and infrastructure transactions, and foreign investment regulation.
He co-heads the firm’s Foreign Investment practice and China practice, and is a former Healthcare Sector Leader.
Jeremy regularly advises boards, sponsors and institutional investors on high‑stakes, cross‑border transactions, particularly those involving competitive processes, sovereign capital and regulated assets. He has a strong reputation for navigating complex stakeholder environments and leading multi‑jurisdictional deal teams on landmark transactions across energy and infrastructure, financial services, healthcare, technology and agribusiness.
Jeremy is recognised by Chambers Global and Chambers Asia‑Pacific in Foreign Investment and Life Sciences.
Jeremy's recent experience includes advising:
- AGL and Tilt Renewables: on the sale of 19.9% of AGL's 20% equity in Tilt Renewables to existing shareholders and other entities led by QIC and the Future Fund for $750m
- Neoen: on the sale of its Victorian renewable energy portfolio to HMC Capital Limited for $950m
- Paine Schwartz Partners (PSP) and a consortium comprised of entities controlled by PSP, Driscoll's and British Columbia Investment Management Corporation: on its acquisition of Costa Group Holdings Limited, Australia's largest horticulture group and a leading grower, packer and marketer of fresh fruit and vegetables, for an enterprise value of $2.459bn by way of scheme of arrangement
- TAB NZ: on its $NZ1.1bn, 25-year strategic partnering arrangement with global sports-betting and gaming giant Entain
- Goldwind: on the sale of 49% of Stockyard Hill Wind Farm (total capacity of up to 528MW) to Palisade Investment Partners and Aware Super and the sale of 49% of Moorabool Wind Farm (total capacity of up to 312MW) to QATAR-based global power and development investment company, Nebras Power
- Pfizer: on its $180m acquisition of ResApp Health, a leading digital health company, by way of scheme of arrangement, on the merger of its UpJohn division with Mylan to form Viatris and the divestment in Australia of certain off-patent branded pharmaceutical products to Aspen Pharmacare, its JV with GSK to create a global consumer healthcare company, its US$17bn acquisition of Hospira, its US$11.9bn sale of its infant nutrition business to Nestlé
- Veolia SA: on its $15bn acquisition of SUEZ SA and on the sale of Veolia and Suez's medical waste and C&I business to Remondis in Australia as part of the transaction
- Vista Equity Partners: on its significant strategic investment in StarRez, a global leading provider of residential community and student housing software solutions
- Spark Consortium (WeBuild, GS E&C, CPB Contractors, China Construction Oceania, Ventia, Capella Capital, John Laing, DIF and Pacific Partnerships): on its consortium arrangements for the $11.1bn North East Link PPP
- Aware Super: on its $675m proposal to acquire OptiComm Limited via an off market takeover and on its successful $2.86bn bid for a concession to operate the land titles and registry functions of Land Use Victoria for a 40-year term.
- A consortium led by Aware Super and Hastings Funds Management: on its successful $2.6bn bid to operate a 35-year concession of the land titling and registry operations of New South Wales Land and Property Information
- First Solar: on the sales of the Manildra Solar Farm and Beryl Solar Farm to ASX listed, New Energy Solar, following a competitive sale process
- Abano Healthcare: a leading Australian and New Zealand dental clinic operator, on its acquisition by BGH and Ontario Teachers' Pension Plan Board
- Nestlé: on its sale of Nestlé Skin Health to a consortium led by EQT and a wholly owned subsidiary of the Abu Dhabi Investment Authority (ADIA) for a value of CHF10.2bn
- DuPont: on the Australian corporate law aspects of its merger of equals with Dow involving the spin out of three publicly traded companies, and DuPont Pioneer on the divestment of its Australian seeds production and distribution business
- Archer Capital: on its sale of private hospital business Healthe Care to China's Luye Medical Group for $938m
- Ingenico Group: on its acquisition of NZ EFTPOS provider Paymark from ANZ, ASB, BNZ and Westpac
- Allianz Australia: on its acquisition from the Northern Territory Government of its privatised general insurance business for $424m
- Beijing Capital Group: on its acquisition from Transpacific Industries Group Ltd of its integrated waste management business in New Zealand for NZ$950m.